Why PLRX? Pliant Therapeutics, Inc. Analysis, Price & AI Insights | Whystock
PLRX
$1.20-0.02 (-1.64%)
After Hours$1.22+0.02 (+1.68%)· Last close May 1
Pliant Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing integrin-based therapeutics for the treatment of solid tumors.